v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Revenue:        
Revenue $ 295,619 $ 309,897 $ 897,804 $ 884,730
Costs and expenses:        
General and administrative expenses 40,966 37,599 117,419 112,604
Merger-related costs 34 4,450 2,416 26,367
Restructuring costs 17 1,547 985 17,885
Depreciation and amortization 17,223 17,931 58,062 52,824
Total costs and expenses 290,676 298,083 867,891 869,640
Loss on impairment 0 (53,249) (24,835) (90,078)
Gain (loss) on disposal of assets 727 1,951 1,388 (1,000)
Earnings (losses) from unconsolidated affiliates, net (860) 896 (1,413) 866
Operating income (loss) 4,810 (38,588) 5,053 (75,122)
Interest income 36 359 144 1,055
Interest expense (10,230) (13,203) (31,280) (39,152)
Loss on extinguishment of debt 0 (229) (124) (844)
Reorganization items, net (29) 1,984 (578) 1,984
Loss on sale of subsidiaries 0 0 (2,002) 0
Change in fair value of preferred stock derivative liability 0 0 0 15,416
Gain on bargain purchase 0 0 0 81,093
Other, net 3,969 5,864 25,483 20,457
Total other income (expense), net (6,254) (5,225) (8,357) 80,009
Income (loss) before income taxes (1,444) (43,813) (3,304) 4,887
Income tax benefit (expense) 1,608 (13,447) (8,034) (18,736)
Net income (loss) 164 (57,260) (11,338) (13,849)
Net (income) loss attributable to noncontrolling interests (220) 139 (141) 343
Net loss attributable to Bristow Group Inc. $ (56) $ (57,121) $ (11,479) $ (13,506)
Income (loss) per common share:        
Basic (in dollars per share) [1] $ 0 $ (1.97) $ (0.40) $ 5.15
Diluted (in dollars per share) [1] $ 0 $ (1.97) $ (0.40) $ 3.58
Weighted average common shares outstanding:        
Basic (in shares) [1] 28,214,650 28,944,908 28,633,875 23,178,914
Diluted (in shares) [1] 28,214,650 28,944,908 28,633,875 32,375,532
Service        
Revenue:        
Revenue $ 285,010 $ 300,275 $ 863,480 $ 857,505
Costs and expenses:        
Operating expenses 221,875 227,031 655,146 632,868
Reimbursable        
Revenue:        
Revenue 10,609 9,622 34,324 27,225
Costs and expenses:        
Operating expenses $ 10,561 $ 9,525 $ 33,863 $ 27,092
[1] See Note 9 to the condensed consolidated financial statements for details on prior year income (loss) per share and weighted average common shares outstanding.

Source